Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Evotec Se (EVOTF)

Evotec Se (EVOTF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow 67.93
  • Price/Book 2.64
Trade EVOTF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.1800 unch
on 04/24/24
10.4400 -2.49%
on 04/24/24
N/A (-26.39%)
since 03/05/24
3-Month
10.1800 unch
on 04/24/24
14.5000 -29.79%
on 02/05/24
-5.8200 (-36.38%)
since 01/17/24
52-Week
10.1800 unch
on 04/24/24
25.4800 -60.05%
on 07/27/23
-10.4700 (-50.70%)
since 03/29/23

Most Recent Stories

More News
Evotec Enters a Drug Discovery Collaboration with Janssen

HAMBURG, GERMANY / ACCESSWIRE / June 14, 2022 / Evotec SE (FRA:EVT)(MDAX/TecDAX)(ISIN:DE0005664809)(NASDAQ:EVO) announced today that the Company has entered a drug discovery collaboration with Janssen...

EVOTF : 10.1800 (-26.39%)
EVT : 24.04 (+0.21%)
EVO : 5.21 (-0.76%)
Evotec and Almirall Enter into a Multi-Target Alliance in Medical Dermatology

HAMBURG, GERMANY and BARCELONA, SPAIN / ACCESSWIRE / May 19, 2022 / Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/TecDAX, ISIN: DE0005664809)(NASDAQ:EVO) and Almirall S.A. (ALM), a global biopharmaceutical...

EVOTF : 10.1800 (-26.39%)
EVT : 24.04 (+0.21%)
EVO : 5.21 (-0.76%)
Evotec SE Fiscal Year 2021 Results: 'Setting the Pace' on the Data-Driven R&D Autobahn to Cures

- STRONG FINANCIAL RESULTS: 23% INCREASE IN GROUP REVENUES SIGNIFICANTLY EXCEEDING GUIDANCE - DATA-DRIVEN PLATFORMS AND TECHNOLOGIES INCREASE PROBABILITIES OF SUCCESS IN ALL MODALITIES - SUBSTANTIALLY...

EVOTF : 10.1800 (-26.39%)
EVO : 5.21 (-0.76%)
Evotec Achieves Programme Designation in Neuroscience Collaboration with Bristol Myers Squibb

- THE PROGRAMME DESIGNATION IS BASED ON AN ANTISENSE-BASED APPROACH WHICH TRIGGERS A US$ 16 M PAYMENT TO EVOTEC BY BRISTOL MYERS SQUIBB - EVOTEC SOURCES LNAPLUS(TM) ANTISENSE TECHNOLOGY THROUGH A STRATEGIC...

EVOTF : 10.1800 (-26.39%)
EVO : 5.21 (-0.76%)
Evotec Receives € 7.5 m Grant for Development of COVID-19 Therapeutic

- EVOTEC RECEIVES A € 7.5 M GRANT FROM THE GERMAN FEDERAL MINISTRY OF EDUCATION AND RESEARCH ("BMBF") FOR THE DEVELOPMENT OF A THERAPEUTIC AGAINST COVID-19 - EVOTEC IS DEVELOPING A HIGHLY POTENT IMMUNOMODULATORY...

EVOTF : 10.1800 (-26.39%)
EVT : 24.04 (+0.21%)
EVO : 5.21 (-0.76%)

Business Summary

Evotec AG was incorporated on December 8, 1993.as Evotec BioSystems GmbH. The Company offers drug research, development, and manufacturing services. It provides integrated drug discovery services and alliances to the pharmaceutical and biotechnology industry. The Company provides solutions to the pharmaceutical...

See More

Key Turning Points

3rd Resistance Point 10.6133
2nd Resistance Point 10.5267
1st Resistance Point 10.3533
Last Price 10.1800
1st Support Level 10.0933
2nd Support Level 10.0067
3rd Support Level 9.8333

See More

52-Week High 25.4800
Fibonacci 61.8% 19.6354
Fibonacci 50% 17.8300
Fibonacci 38.2% 16.0246
Last Price 10.1800
52-Week Low 10.1800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar